Q&A

Optimizing The Development And Upscaling Of API / HPAPI And Fermentation Projects

Evonik-

Pharmaceutical and biopharmaceutical projects for the development and upscaling of APIs, HPAPIs and intermediates continue to increase in process complexity. In this interview, Dr. Ingo Klement, Director, Global Business Development for Exclusive Synthesis at Evonik, shares some of the key expectations of customers who are reviewing CMOs to support the development and upscaling of their next major project.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: